GTCM
BNR

Gyon Technologies Capital Management’s Burning Rock Biotech BNR Stock Holding History

Gyon Technologies Capital Management’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,010
Closed -$94K – 471
2022
Q1 		$94K Sell
1,010
-5,799
-85% -$504K 0.07% 251
2021
Q4 		$649K Buy
+6,809
New +$933K 0.12% 235

Other funds holding BNR

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Gyon Technologies Capital Management's BNR Position: Q2 2022 in Review

Gyon Technologies Capital Management sold out of Burning Rock Biotech (BNR) in Q2 2022, closing a stake of 1,010 shares — an estimated $94K sold.

Gyon Technologies Capital Management first reported a position in BNR in Q4 2021 and held it in 2 quarters. The position peaked at $649K in Q4 2021. 50 funds tracked by Wall St. Rank hold BNR as of Q2 2022.

  • Gyon Technologies Capital Management reported no remaining Burning Rock Biotech position as of Q2 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 1,010 Burning Rock Biotech shares in Q2 2022, an estimated $94K.
  • Gyon Technologies Capital Management first reported a position in Burning Rock Biotech in Q4 2021 and held it in 2 quarters.
  • Gyon Technologies Capital Management's Burning Rock Biotech position peaked at $649K in Q4 2021.
  • 50 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.